Label: LATANOPROST PF solution/ drops

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated May 8, 2018

If you are a consumer or patient please visit this version.

View All Sections
  • STORAGE AND HANDLING

    Store under refrigeration 2° to 8° C (36° to 46° F)

  • Bottle Label

    Bottle Label

  • INGREDIENTS AND APPEARANCE
    LATANOPROST PF 
    latanoprost pf solution/ drops
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70261-515
    Route of AdministrationOPHTHALMIC
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LATANOPROST (UNII: 6Z5B6HVF6O) (LATANOPROST - UNII:6Z5B6HVF6O) LATANOPROST0.05 mg  in 1 mL
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70261-515-077.5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product01/01/2018
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other01/01/2018
    Labeler - ImprimisRx NJ (931390178)
    Registrant - ImprimisRx NJ (931390178)
    Establishment
    NameAddressID/FEIBusiness Operations
    Imprimis Pharmaceuticals080431967manufacture(70261-515)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!